Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
20,995.980000 Euro
Request Reference:
ULS, DE SÃO JOSÉ - 51025324
Request Name:
AQUISIÇÃO DE ERLOTINIB 100 MG COMP E ERLOTINIB 150 MG COMP (DOENTES AUTORIZADOS)
Phase:
Tendering Phase
State:
Awarded
Description:
AQUISIÇÃO DE ERLOTINIB 100 MG COMP E ERLOTINIB 150 MG COMP (DOENTES AUTORIZADOS)
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
E367 - ERLOTINIB [100 MG; CÁP/COMP]
-
8
(
Months
)
E239 - ERLOTINIB [150 MG; CÁP/COMP]
-
8
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
4/26/2024 5:14 PM
(UTC +1 hour)
National official publishing date and time (DR):
9/4/2023 4:58 PM
(UTC +1 hour)
Due datetime for receiving replies:
4/30/2024 4:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Convite 51025324.pdf
Convite 51025324.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Lot Title
E367 - ERLOTINIB [100 MG; CÁP/COMP]
Base Price
9 264,000000
1.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
10069800
ERLOTINIB [100 MG; CÁP/COMP]
300,000000
NXTWY.UMT.17648
Buyer Comment:
500233810 | Roche - Farmacêutica Química, Lda. | CPA:2023491/150/0397 | NºAIM:5600986; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023491/326/0641 | NºAIM:5744560; 507045491 | Teva Pharma - Produtos Farmacêuticos, Lda. | CPA:2023491/334/0090 | NºAIM:5745617;
TOTAL
(The amounts shown do not include VAT)
2
Lot Title
E239 - ERLOTINIB [150 MG; CÁP/COMP]
Base Price
11 731,980000
2.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
10043410
ERLOTINIB [150 MG; CÁP/COMP]
300,000000
NXTWY.UMT.17648
Buyer Comment:
500233810 | Roche - Farmacêutica Química, Lda. | CPA:2023491/150/0396 | NºAIM:5601083; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2023491/326/0639 | NºAIM:5744552; 507045491 | Teva Pharma - Produtos Farmacêuticos, Lda. | CPA:2023491/334/0088 | NºAIM:5745625;
TOTAL
(The amounts shown do not include VAT)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Monofator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - E367 - ERLOTINIB [100 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
2 - E239 - ERLOTINIB [150 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
-
100%
Normas de desempate
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...